Upstream Bio, Inc.
UPB
$9.71
$0.9310.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 613.00K | 607.00K | 575.00K | 575.00K | 450.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 613.00K | 607.00K | 575.00K | 575.00K | 450.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 613.00K | 607.00K | 575.00K | 575.00K | 450.00K |
| SG&A Expenses | 5.16M | 4.07M | 3.97M | 3.97M | 3.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.93M | 19.50M | 16.85M | 16.85M | 14.78M |
| Operating Income | -26.32M | -18.89M | -16.28M | -16.28M | -14.33M |
| Income Before Tax | -21.24M | -15.99M | -12.79M | -12.79M | -11.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.24M | -15.99M | -12.79M | -12.79M | -11.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.24M | -15.99M | -12.79M | -12.79M | -11.83M |
| EBIT | -26.32M | -18.89M | -16.28M | -16.28M | -14.33M |
| EBITDA | -26.27M | -18.88M | -16.26M | -16.26M | -14.32M |
| EPS Basic | -0.48 | -6.96 | -5.87 | -5.87 | -5.03 |
| Normalized Basic EPS | -0.29 | -3.31 | -2.79 | -2.79 | -2.48 |
| EPS Diluted | -0.48 | -6.96 | -5.87 | -5.87 | -5.03 |
| Normalized Diluted EPS | -0.29 | -3.31 | -2.79 | -2.79 | -2.48 |
| Average Basic Shares Outstanding | 45.70M | 3.02M | 2.86M | 2.86M | 2.98M |
| Average Diluted Shares Outstanding | 45.70M | 3.02M | 2.86M | 2.86M | 2.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |